Capsaicin in hot chili pepper: Carcinogen, co-carcinogen or anticarcinogen?

Food and Chemical Toxicology

Volumn 34, Issue 3, 1996, Pages 313-316

  Surh, Y J ^a   Lee, S S ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN;

CANCER PREVENTION; CARCINOGENESIS; CARCINOGENICITY; DRUG TOXICITY; HUMAN; MUTAGENESIS; MUTAGENICITY; NONHUMAN; PEPPER; REVIEW;

CAPSICUM; CAPSICUM ANNUUM VAR. ANNUUM; CAPSICUM FRUTESCENS;

EID: 0029928940     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-6915(95)00108-5     Document Type: Review

References (48)

1. Agrawal R. C. Wiessler M., Hecker E. and Bhide S. V. (1986) Tumour promoting effects of chilli extract in BALB/c mice. International Journal of Cancer 38, 689-695.
2. Azizan A. and Blevins R. D. (1995) Mutagenicity and antimutagenicity testing of six chemicals associated with the pungent properties of specific spices as revealed by the Ames Salmonella/microsome assay. Archives of Environmental Contamination and Toxicology 28, 248-258.
3. Buchanan R. L., Goldstein S. and Budroe J. D. (1981) Examination of chili pepper and nutmeg oleoresins using the Salmonella/mammalian microsome mutagenicity assay. Journal of Food Science 47, 330-333.
4. Buck S. H. and Burks T. F. (1986) The neuropharmacology of capsaicin: review of some recent observations. Pharmacological Reviews 38, 179-226.
5. Carter R. B. (1991) Topical capsaicin in the treatment of cutaneous disorders. Drug Development and Research 22, 109-123.
6. Cordell G. A. and Araujo O. E. (1993) Capsaicin: identification, nomenclature, and pharmacotherapy. Annals of Pharmacotherapy 21, 330-336.
7. Dray A. (1992) Neuropharmacological mechanisms of capsaicin and related substances. Biochemical Pharmacology 44, 611-615.
8. Dubner R. (1991) Topical capsaicin therapy for neuropathic pain. Pain 47, 247-249.
9. Ferguson L. R. (1994) Antimutagens as cancer chemopreventive agents in the diet. Mutation Research 307, 395-410.
10. Gannett P. M., Iversen P. and Lawson T. (1990) The mechanism of inhibition of cytochrome P450IIE1 by dihydrocapsaicin. Bioorganic Chemistry 18, 185-198.
11. Gannett P. M., Nagel D. L., Reilly P. J., Lawson T., Sharpe J. and Toth B. (1988) The capsaicinoids: their separation, synthesis, and mutagenicity. Journal of Organic Chemistry 53, 1064-1071.
12. Govindarajan V. S., and Sathyanarayana M. N. (1991) Capsicum-production, technology, chemistry, and quality. Part V. Impact on physiology, pharmacology, nutrition, and metabolism: structure, pungency, pain, and desensitization sequences. CRC Critical Reviews in Food Science and Nutrition 29, 435-474.
13. 6-ethenoadenosine. Chemical Research in Toxicology 4, 413-421.
14. Guengerich F. P., Kim D. H. and Iwasaki M. (1991) Role of human P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology 4, 168-179.
15. Guengerich F. P., Shimada T., Yun C.-H., Yamazaki H., Raney K. D., Thier R., Coles B. and Harris T. M. (1994) Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environmental Health Perspectives 102 (suppl. 9), 49-53.
16. Hoch-Ligeti C. (1952) Naturally occurring dietary agents and their role in production of tumors. Texas Reports on Biology and Medicine 10, 996-1005.
17. Holzer P. (1991) Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacological Reviews 43, 143-201.
18. Jang J. J. and Kim S. H. (1988) The promoting effect of capsaicin on the development of diethylnitrosamine-induced enzyme altered hepatic foci in male Sprague-Dawley rats. Journal of the Korean Cancer Association 20, 1-7.
19. Kang J. Y., Alexander B., Barker F., Man W. K. and Williamson R. C. N. (1992) The effect of chilli ingestion of gastrointestinal mucosal proliferation and azoxymethane-induced cancer in the rat. Journal of Gastroenterology and Hepatology 7, 194-198.
20. Kim J. P., Park J. G., Lee M. D., Han M. D., Park S. T., Lee B. H. and Jung S. E. (1985) Co-carcinogenic effects of several Korean foods on gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Japanese Journal of Surgery 15, 427-437.
21. Kim S.-H., Park K.-Y. and Suh M.-J. (1991) Inhibitory effect of aflatoxin B1 mediated mutagenicity by red pepper powder in the Salmonella assay system. Journal of the Korean Society of Food and Nutrition 20, 156-161.
22. Lawson T. and Gannett P. (1989) The mutagenicity of capsaicin and dihydrocapsaicin in V79 cells. Cancer Letters 49, 109-113.
23. Lee S. S. and Kumar S. (1980) Metabolism in vitro of capsaicin, a pungent principle of red pepper, with rat liver homogenates. In Microsomes, Drug Oxidations, and Chemical Carcinogenesis. Edited by M. J. Coon, A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette and P. J. O'Brien. Vol. 2. pp. 1009-1012. Academic Press, New York.
24. López-Carillo L., Avila M. H. and Dubrow R. (1994) Chili pepper consumption and gastric cancer in Mexico: a case control study. American Journal of Epidemiology 139, 263-271.
25. Lotz M. (1994) Experimental models of arthritis: identification of substance P as a therapeutic target and use of capsaicin to manage joint pain and inflammation. Seminars in Arthritis and Rheumatism 23 (suppl. 3), 10-17.
26. Maggi C. A. (1991) Capsaicin and primary afferent neurons: from basic science to human therapy? Journal of the Autonomic Nervous System 33, 1-14.
27. Miller M. S., Brendel K., Burks T. F. and Sipes I. G. (1983) Interactions of capsaicinoids with drug-metabolizing systems. Biochemical Pharmacology 32, 547-551.
28. Miller C. H., Zhang Z., Hamilton S. M. and Teel R. W. (1993) Effects of capsaicin on liver microsomal metabolism of the tobacco-specific nitrosamine NNK. Cancer Letters 75, 45-52.
29. Modly C. E., Das M., Don P. S. C., Marcelo C. L., Mukhtar H. and Bickers D. R. (1986) Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 14, 413-416.
30. Monsereenusorn Y., Kongsamut S. and Pezalla P. D. (1982) Capsaicin - a literature survey. CRC Critical Reviews in Toxicology 10, 321-339.
31. Muralidhara and Narasimhamurthy K. (1988) Non-mutagenicity of capsaicin in albino mice. Food and Chemical Toxicology 26, 955-958.
32. Nagabhushan M. and Bhide S. V. (1985) Mutagenicity of chili extract and capsaicin in short-term tests. Environmental Mutagenesis 7, 881-888.
33. Nagabhushan M. and Bhide S. V. (1986) Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutrition and Cancer 8, 201-210.
34. Park K.-K., Liem A., Stewart B. C. and Miller J. A. (1993) Vinyl carbamate epoxide, a major strong electrophilic, mutagenic and carcinogenic metabolite of vinyl carbamate and ethyl carbamate (urethane). Carcinogenesis 14, 441-450.
35. Shlyankevich M., Lee R., Garden K., Lee Y.-C. and Surh Y.-J. (1995) Inhibitory effects of capsaicin and diallyl sulfide on dimethylnitrosamine-induced mutagenesis. Advances in Experimental Medicine and Biology 375, 212.
36. Stavric B. (1994) Role of chemopreventers in human diet. Clinical Biochemistry 27, 319-332.
37. Surh Y.-J. and Lee S. S. (1995) Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sciences 56, 1845-1855.
38. Surh Y.-J., Lee R. C.-J., Park K.-K., Mayne S. T., Liem A. and Miller J. A. (1995) Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis 16, 2467-2471.
39. Szallasi A. and Blumberg P. M. (1990) Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor. Life Sciences 47, 1399-1408.
40. Teel R. W. (1991) Effects of capsaicin on rat liver S9-mediated metabolism and DNA binding of aflatoxin. Nutrition and Cancer 15, 27-32.
41. Teel R. W. (1993) Effects of phytochemicals on the mutagenicity of the tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium strain TA1535. Phytotherapy Research 7, 248-251.
42. Toth B. and Gannett P. (1992) Carcinogenicity of lifelong administration of capsaicin of hot pepper in mice. In Vivo 6, 59-63.
43. Toth B., Rogan E. and Walker B. (1984) Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Research 4, 117-119.
44. Unnikrishnan M. C. and Kuttan R. (1990) Tumor reducing and anticarcinogenic activity of selected spices. Cancer Letters 51, 85-89.
45. Villasenor I. M. and de Ocampo E. J. (1994) Clastogenicity of red pepper (Capsicum frutescens L.) extracts. Mutation Research 312, 151-155.
46. Vinitketkumnuen U., Sasagwa C. and Matsushima T. (1991) Mutagenicity study of chili and its pungent principles, capsaicin and dihydrocapsaicin. Mutation Research 215, 115 (abstract no. 81).
47. Yang C. S., Yoo J.-S. H., Ishizaki H. and Hong J. (1990) Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metabolism Reviews 22, 147-159.
48. Zhang Z., Hamilton S. M., Stewart S. M., Stewart C., Stoner A. and Teel R. W. (1993) Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Research 13, 2341-2346.